G(Anh)MTetra/NN
,/,
a/DT
natural/JJ
bacterial/JJ
cell/NN
wall/NN
breakdown/NN
product/NN
,/,
induces/VBZ
interleukin-1/NN
beta/NN
and/CC
interleukin-6/NN
expression/NN
in/IN
human/JJ
monocytes/NNS
./.
=====
A/DT
study/NN
of/IN
the/DT
molecular/JJ
mechanisms/NNS
involved/VBN
in/IN
inflammatory/JJ
cytokine/NN
expression/NN
[/(
published/VBN
erratum/NN
appears/VBZ
in/IN
J/NNP
Biol/NNP
Chem/NNP
1994/CD
Jun/NNP
17/CD
;/:
269/CD
(/(
24/CD
)/)
:/:
16983/CD
]/)

It/PRP
is/VBZ
believed/VBN
that/IN
induction/NN
of/IN
cytokine/NN
expression/NN
by/IN
bacterial/JJ
cell/NN
wall/NN
components/NNS
plays/VBZ
a/DT
role/NN
in/IN
the/DT
development/NN
and/CC
course/NN
of/IN
sepsis/NN
./.
=====
However/RB
,/,
most/JJS
attention/NN
has/VBZ
been/VBN
focused/VBN
on/IN
lipopolysaccharide/NN
(/(
LPS/NN
)/)
./.
=====
We/PRP
studied/VBD
the/DT
ability/NN
of/IN
N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-L-alanyl-D- isoglutamyl-m-diaminopimelyl-D-alanine/NN
(/(
G(Anh)MTetra/NN
)/)
,/,
a/DT
naturally/RB
occurring/VBG
breakdown/NN
product/NN
of/IN
peptidoglycan/NN
that/WDT
is/VBZ
produced/VBN
by/IN
soluble/JJ
lytic/JJ
transglycosylase/NN
of/IN
Escherichia/FW
coli/FW
,/,
to/TO
induce/VB
cytokine/NN
expression/NN
in/IN
human/JJ
monocytes/NNS
./.
=====
G(Anh)MTetra/NN
was/VBD
found/VBN
to/TO
strongly/RB
induce/VB
interleukin/NN
(/(
IL/NN
)/)
-1/CD
beta/NN
and/CC
IL-6/NN
mRNA/NN
expression/NN
after/IN
2/CD
h/NN
and/CC
IL-1/NN
beta/NN
and/CC
IL-6/NN
protein/NN
secretion/NN
after/IN
48/CD
h/NN
of/IN
activation/NN
./.
=====
The/DT
increase/NN
in/IN
mRNA/NN
accumulation/NN
was/VBD
at/IN
least/JJS
partly/RB
due/JJ
to/TO
an/DT
increase/NN
in/IN
the/DT
transcription/NN
rates/NNS
of/IN
the/DT
respective/JJ
genes/NNS
and/CC
was/VBD
accompanied/VBN
by/IN
a/DT
strong/JJ
induction/NN
of/IN
nuclear/JJ
factor-kappa/NN
B/NN
and/CC
activator/NN
protein-1/NN
transcription/NN
factor/NN
expression/NN
./.
=====
Experiments/NNS
using/VBG
inhibitors/NNS
of/IN
protein/NN
kinase/NN
C/NN
,/,
protein/NN
kinase/NN
A/NN
,/,
and/CC
tyrosine/NN
kinase-dependent/JJ
pathways/NNS
revealed/VBD
that/IN
G(Anh)MTetra-induced/JJ
IL-1/NN
beta/NN
and/CC
IL-6/NN
mRNA/NN
expression/NN
involves/VBZ
activation/NN
of/IN
an/DT
H7-inhibitable/JJ
pathway/NN
./.
=====
By/IN
using/VBG
the/DT
protein/NN
synthesis/NN
inhibitor/NN
cycloheximide/NN
,/,
it/PRP
was/VBD
shown/VBN
that/IN
G(Anh)MTetra-induced/JJ
IL-6/NN
mRNA/NN
expression/NN
depends/VBZ
on/IN
the/DT
synthesis/NN
of/IN
new/JJ
protein/NN
,/,
whereas/IN
G(Anh)MTetra-induced/JJ
IL-1/NN
beta/NN
mRNA/NN
accumulation/NN
does/VBZ
not/RB
./.
=====
When/WRB
responses/NNS
to/TO
G(Anh)MTetra/NN
were/VBD
compared/VBN
with/IN
those/DT
to/TO
LPS/NN
and/CC
muramyldipeptide/NN
(/(
MDP/NN
)/)
,/,
it/PRP
was/VBD
found/VBN
that/IN
the/DT
optimal/JJ
response/NN
to/TO
G(Anh)MTetra/NN
induction/NN
was/VBD
similar/JJ
to/TO
that/DT
of/IN
LPS/NN
but/CC
significantly/RB
higher/JJR
than/IN
the/DT
response/NN
to/TO
MDP/NN
./.
=====
Furthermore/RB
,/,
maximal/JJ
G(Anh)MTetra-induced/JJ
IL-1/NN
beta/NN
and/CC
IL-6/NN
mRNA/NN
expression/NN
could/MD
be/VB
enhanced/VBN
by/IN
co-stimulation/NN
with/IN
LPS/NN
or/CC
MDP/NN
,/,
suggesting/VBG
that/IN
different/JJ
receptors/NNS
and/or/CC
transduction/NN
pathways/NNS
were/VBD
involved/VBN
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
G(Anh)MTetra/NN
induces/VBZ
IL-1/NN
beta/NN
and/CC
IL-6/NN
expression/NN
in/IN
human/JJ
monocytes/NNS
suggesting/VBG
a/DT
possible/JJ
role/NN
for/IN
G(Anh)MTetra/NN
in/IN
the/DT
release/NN
of/IN
cytokines/NNS
during/IN
sepsis/NN
./.